CLINICAL_TRIALS
trial_result
· 2021-11-17
Clinical Trial Update: A Study of Orelabrutinib in Patients With ITP [Phase 1, Phase 2]
Summary
Clinical trial update for orelabrutinib in immune thrombocytopenia (ITP) across Phase 1 and Phase 2.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Peking University People's Hospital | Conditions: Immune Thrombocytopenia | Phase 1, Phase 2 | Status: UNKNOWN